- Exchange: Stockholm
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Oasmia Pharmaceutical AB+ Add to Watchlist
OASM:SS19.2000 SEK 0.2000 1.05%
As of 07:21:11 ET on 05/06/2015.
Company Profile for Oasmia Pharmaceutical AB (OASM)
Oasmia Pharmaceutical AB is a pharmaceutical company that specializes in human and veterinary oncology. The Company's develops the semi-synthesized substances for different therapeutic areas, primarily for anti-cancer chemotherapy. Oasmia also conducts research within antibiotics, asthma and neurologically targeted drugs in clinical or preclinical stages.
Oasmia Pharmaceutical AB
Key Executives for Oasmia Pharmaceutical AB (OASM)
|Joel Tomas CitronChairman||Julian AleksovPresident/CEO/Co-Founder|
|Anders BlomExec Vice President||Margareta ErikssonVP:Clinical Development|
|Ingela HagglundVP:Operations||Annette LjungmarkHead:Accounting & Human Resources|
|Mikael AspHead:Quality Assurance|